You just read:

CTI BioPharma Begins Patient Enrollment in PACIFICA Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis Patients With Severe Thrombocytopenia

News provided by

CTI BioPharma Corp.

Oct 01, 2019, 07:00 ET